It binds DNA through a pyrrole- and imidazole-based polyamide specific for the sequence AAGAAGAAG, which is dramatically expanded in the genome of Friedreich's ataxia's patients.
Its other half is a drug (JQ1) that recruits the transcription elongation factor BRD4, which rescues expression of the mutated gene.
This Mastodon instance is for people interested in technology. Discussions aren't limited to technology, because tech folks shouldn't be limited to technology either!
Hosting costs are largely covered by our generous supporters on Patreon – thanks for all the help!